首页 > 最新文献

Health Promotion Perspectives最新文献

英文 中文
Dietary linoleic acid intake in relation to breast cancer: A case-control study. 饮食亚油酸摄入与癌症的关系:一项病例对照研究。
IF 4.4 Q1 Social Sciences Pub Date : 2023-09-11 eCollection Date: 2023-01-01 DOI: 10.34172/hpp.2023.27
Muhammad Reza Joya, Sina Naghshi, Omid Sadeghi, Sanaz Benisi-Kohansal, Leila Azadbakht, Keyhan Lotfi, Alireza Ostadrahimi, Helda Tutunchi, Ahmad Esmaillzadeh

Background: The present study aimed to investigate the association between dietary linoleic acid (LA) intake and breast cancer in women.

Methods: In this population-based case-control study, we enrolled 350 pathologically confirmed breast cancer cases and 700 controls which were matched with cases in terms of age and socioeconomic status. Dietary intakes were assessed using a 106-item Willett-format semi-quantitative dish-based food frequency questionnaire (DS-FFQ). Odds ratios (ORs) and the corresponding 95% confidence intervals (CIs) were estimated.

Results: A significant inverse association was found between LA intake and odds of breast cancer (OR: 0.41, 95% CI: 0.30-0.56). After adjusting for potential confounders, women in the highest tertile of dietary LA intake were 48% less likely to have breast cancer compared with those in the lowest tertile (OR: 0.52, 95% CI: 0.28-0.95). Such a significant inverse association was also seen among normal-weight women (OR: 0.29, 95% CI: 0.14-0.63), and premenopausal women (OR: 0.15, 95% CI: 0.02-0.95).

Conclusion: The findings of current study provide evidence for a protective role of LA against breast cancer particularly among normal-weight and premenopausal women. Prospective studies are needed to confirm this association.

背景:本研究旨在探讨女性饮食亚油酸(LA)摄入量与乳腺癌症的关系。方法:在这项基于人群的病例对照研究中,我们纳入了350例经病理证实的癌症病例和700例对照,这些病例在年龄和社会经济状况方面与病例相匹配。饮食摄入量使用106项威利特格式的半定量菜肴食物频率问卷(DS-FFQ)进行评估。估计了比值比(OR)和相应的95%置信区间(CI)。结果:LA摄入量与癌症发生率呈显著负相关(OR:0.41,95%CI:0.30-0.56),饮食摄入LA最高三分位数的女性患癌症的可能性比最低三分位数女性低48%(OR:0.52,95%CI:0.28-0.95)。在正常体重女性中也发现了这种显著的负相关(OR:0.29,95%CI:0.14-0.63),结论:本研究结果为LA对乳腺癌症的保护作用提供了证据,尤其是在正常体重和绝经前妇女中。需要进行前瞻性研究来证实这种关联。
{"title":"Dietary linoleic acid intake in relation to breast cancer: A case-control study.","authors":"Muhammad Reza Joya,&nbsp;Sina Naghshi,&nbsp;Omid Sadeghi,&nbsp;Sanaz Benisi-Kohansal,&nbsp;Leila Azadbakht,&nbsp;Keyhan Lotfi,&nbsp;Alireza Ostadrahimi,&nbsp;Helda Tutunchi,&nbsp;Ahmad Esmaillzadeh","doi":"10.34172/hpp.2023.27","DOIUrl":"10.34172/hpp.2023.27","url":null,"abstract":"<p><strong>Background: </strong>The present study aimed to investigate the association between dietary linoleic acid (LA) intake and breast cancer in women.</p><p><strong>Methods: </strong>In this population-based case-control study, we enrolled 350 pathologically confirmed breast cancer cases and 700 controls which were matched with cases in terms of age and socioeconomic status. Dietary intakes were assessed using a 106-item Willett-format semi-quantitative dish-based food frequency questionnaire (DS-FFQ). Odds ratios (ORs) and the corresponding 95% confidence intervals (CIs) were estimated.</p><p><strong>Results: </strong>A significant inverse association was found between LA intake and odds of breast cancer (OR: 0.41, 95% CI: 0.30-0.56). After adjusting for potential confounders, women in the highest tertile of dietary LA intake were 48% less likely to have breast cancer compared with those in the lowest tertile (OR: 0.52, 95% CI: 0.28-0.95). Such a significant inverse association was also seen among normal-weight women (OR: 0.29, 95% CI: 0.14-0.63), and premenopausal women (OR: 0.15, 95% CI: 0.02-0.95).</p><p><strong>Conclusion: </strong>The findings of current study provide evidence for a protective role of LA against breast cancer particularly among normal-weight and premenopausal women. Prospective studies are needed to confirm this association.</p>","PeriodicalId":46588,"journal":{"name":"Health Promotion Perspectives","volume":null,"pages":null},"PeriodicalIF":4.4,"publicationDate":"2023-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558966/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41153153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medications Non-adherence Reasoning Scale (MedNARS): Development and psychometric properties appraisal. 药物不依从性推理量表(MedNARS):发展和心理测量特性评估。
IF 4.4 Q1 Social Sciences Pub Date : 2023-09-11 eCollection Date: 2023-01-01 DOI: 10.34172/hpp.2023.26
Hamid Allahverdipour, Majid Badri, Abdolreza Shaghaghi, Hassan Mahmoodi, Haleh Heizomi, Shayesteh Shirzadi, Mohammad Asghari-Jafarabadi

Background: Proper elucidation of medication non-adherence reasoning especially in older adults might pave the way for an auspicious therapeutic outcome. The main aim of this study was to develop and psychometrically test the Medications Non-adherence Reasoning (MedNARS) questionnaire for application in research and probably practice settings.

Methods: A mixed methods design was utilized to develop the MedNARS. The item pool was mainly generated based on a qualitative query and literature review. The expert panel approved version of the MedNARS was psychometrically assessed on a convenience sample of 220 older patients with chronic disease. The internal consistency, test-retest reliability, content and face validity of the scale were appraised and its construct validity was assed using exploratory and confirmatory factor analyses.

Results: A nine-item version of the MedNARS was drafted based on the classical item analysis procedures and its estimated internal consistency measure of the Cronbach's alpha (0.85) and test-retest reliability (0.96) were in the vicinity of acceptable range. The exploratory factor analysis (EFA) output revealed a unidimensional structure for the MedNARS and the conducted confirmatory factor analysis (CFA) indicated an acceptable data fit for the extracted one-factor model. The goodness of fit indices were as the followings: χ2 /df=1.63(90% CI: 0.02 to 0.11), root mean squared error of approximation (RMSEA)=(0.07), comparative fit index (CFI)=0.95, Tucker-Lewis index (TLI)=0.93 and standardized root mean squared residual (SRMSR)=(0.05).

Conclusion: The study findings were indicative of MedNARS's applicability and feasibility for use in assessment of medication non-adherence reasoning among the elderly patients with chronic diseases. The MedNARS as a brief and elder-friendly instrument can be applied both in research and practice settings to enhance efficiency, safety, and health outcomes of the therapeutic recommendations.

背景:适当阐明药物不依从性的理由,尤其是在老年人中,可能会为良好的治疗结果铺平道路。本研究的主要目的是开发和心理测量测试药物不依从性推理(MedNARS)问卷,以应用于研究和可能的实践环境。方法:采用混合方法设计MedNARS。项目库主要基于定性查询和文献综述生成。专家小组批准的MedNARS版本是在220名老年慢性病患者的方便样本上进行心理测量评估的。采用探索性和验证性因素分析对量表的内部一致性、重测信度、内容和面效性进行了评价,并对其结构有效性进行了评定。结果:MedNARS的九项版本是基于经典项目分析程序起草的,其Cronbachα(0.85)和重测可靠性(0.96)的内部一致性估计值在可接受范围附近。探索性因素分析(EFA)的输出揭示了MedNARS的一维结构,而进行的验证性因素分析表明,所提取的单因素模型的数据符合可接受的要求。拟合优度指数为:χ2/df=1.63(90%CI:0.02~0.11),近似均方根误差(RMSEA)=(0.07),比较拟合指数(CFI)=0.95,Tucker Lewis指数(TLI)=0.93,标准化均方根残差(SRMSR)=(0.05)。结论:研究结果表明MedNARS在评估老年慢性病患者药物不依从性推理中的适用性和可行性。MedNARS作为一种简短且对老年人友好的仪器,可以应用于研究和实践环境中,以提高治疗建议的效率、安全性和健康结果。
{"title":"Medications Non-adherence Reasoning Scale (MedNARS): Development and psychometric properties appraisal.","authors":"Hamid Allahverdipour,&nbsp;Majid Badri,&nbsp;Abdolreza Shaghaghi,&nbsp;Hassan Mahmoodi,&nbsp;Haleh Heizomi,&nbsp;Shayesteh Shirzadi,&nbsp;Mohammad Asghari-Jafarabadi","doi":"10.34172/hpp.2023.26","DOIUrl":"10.34172/hpp.2023.26","url":null,"abstract":"<p><strong>Background: </strong>Proper elucidation of medication non-adherence reasoning especially in older adults might pave the way for an auspicious therapeutic outcome. The main aim of this study was to develop and psychometrically test the Medications Non-adherence Reasoning (MedNARS) questionnaire for application in research and probably practice settings.</p><p><strong>Methods: </strong>A mixed methods design was utilized to develop the MedNARS. The item pool was mainly generated based on a qualitative query and literature review. The expert panel approved version of the MedNARS was psychometrically assessed on a convenience sample of 220 older patients with chronic disease. The internal consistency, test-retest reliability, content and face validity of the scale were appraised and its construct validity was assed using exploratory and confirmatory factor analyses.</p><p><strong>Results: </strong>A nine-item version of the MedNARS was drafted based on the classical item analysis procedures and its estimated internal consistency measure of the Cronbach's alpha (0.85) and test-retest reliability (0.96) were in the vicinity of acceptable range. The exploratory factor analysis (EFA) output revealed a unidimensional structure for the MedNARS and the conducted confirmatory factor analysis (CFA) indicated an acceptable data fit for the extracted one-factor model. The goodness of fit indices were as the followings: χ<sup>2</sup> /df=1.63(90% CI: 0.02 to 0.11), root mean squared error of approximation (RMSEA)=(0.07), comparative fit index (CFI)=0.95, Tucker-Lewis index (TLI)=0.93 and standardized root mean squared residual (SRMSR)=(0.05).</p><p><strong>Conclusion: </strong>The study findings were indicative of MedNARS's applicability and feasibility for use in assessment of medication non-adherence reasoning among the elderly patients with chronic diseases. The MedNARS as a brief and elder-friendly instrument can be applied both in research and practice settings to enhance efficiency, safety, and health outcomes of the therapeutic recommendations.</p>","PeriodicalId":46588,"journal":{"name":"Health Promotion Perspectives","volume":null,"pages":null},"PeriodicalIF":4.4,"publicationDate":"2023-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558970/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41173315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preparing for future outbreaks in Ghana: An overview of current COVID-19, monkeypox, and Marburg disease outbreaks. 为加纳未来疫情做好准备:当前新冠肺炎、猴痘和马尔堡病疫情概述。
IF 4.4 Q1 Social Sciences Pub Date : 2023-09-11 eCollection Date: 2023-01-01 DOI: 10.34172/hpp.2023.25
Isaac Owusu, Collins Adu, Richard Gyan Aboagye, Rebecca Ann Mpangah, Gideon K Acheampong, Ernest Akyereko, Emmanuel Osei Bonsu, Prince Peprah

Amidst the ongoing COVID-19 pandemic, Ghana is currently grappling with simultaneous outbreaks of Marburg virus disease and human monkeypox virus. The coexistence of these outbreaks emphasizes the imperative for a collaborative and global approach to enhance surveillance and expedite case detection. While Ghana has made efforts to respond to these outbreaks, this paper outlines the lessons learned and proposes recommendations in this regard. It is crucial to intensify response efforts at the local, regional, and national levels to effectively contain the spread of these infectious diseases. Therefore, this paper suggests prioritizing the following recommendations as crucial for assisting Ghana in adequately preparing for future outbreaks and safeguarding global public health: strengthening surveillance system through digitization, rapid and effective response; risk communication and community engagement; healthcare system readiness; and research and collaboration. Also, prioritizing building healthy public policies and developing personal skills of health personnel across the country is key for future outbreak response.

在持续的新冠肺炎大流行中,加纳目前正在努力应对马尔堡病毒病和人类猴痘病毒的同时爆发。这些疫情的共存强调了采取合作和全球方法加强监测和加快病例检测的必要性。虽然加纳努力应对这些疫情,但本文概述了所吸取的经验教训,并提出了这方面的建议。至关重要的是要加强地方、区域和国家各级的应对工作,以有效遏制这些传染病的传播。因此,本文建议优先考虑以下建议,这些建议对于协助加纳为未来疫情做好充分准备和保障全球公共卫生至关重要:通过数字化、快速有效的应对措施加强监测系统;风险沟通和社区参与;医疗系统准备情况;以及研究与合作。此外,优先制定健康的公共政策和发展全国卫生人员的个人技能是未来应对疫情的关键。
{"title":"Preparing for future outbreaks in Ghana: An overview of current COVID-19, monkeypox, and Marburg disease outbreaks.","authors":"Isaac Owusu,&nbsp;Collins Adu,&nbsp;Richard Gyan Aboagye,&nbsp;Rebecca Ann Mpangah,&nbsp;Gideon K Acheampong,&nbsp;Ernest Akyereko,&nbsp;Emmanuel Osei Bonsu,&nbsp;Prince Peprah","doi":"10.34172/hpp.2023.25","DOIUrl":"10.34172/hpp.2023.25","url":null,"abstract":"<p><p>Amidst the ongoing COVID-19 pandemic, Ghana is currently grappling with simultaneous outbreaks of Marburg virus disease and human monkeypox virus. The coexistence of these outbreaks emphasizes the imperative for a collaborative and global approach to enhance surveillance and expedite case detection. While Ghana has made efforts to respond to these outbreaks, this paper outlines the lessons learned and proposes recommendations in this regard. It is crucial to intensify response efforts at the local, regional, and national levels to effectively contain the spread of these infectious diseases. Therefore, this paper suggests prioritizing the following recommendations as crucial for assisting Ghana in adequately preparing for future outbreaks and safeguarding global public health: strengthening surveillance system through digitization, rapid and effective response; risk communication and community engagement; healthcare system readiness; and research and collaboration. Also, prioritizing building healthy public policies and developing personal skills of health personnel across the country is key for future outbreak response.</p>","PeriodicalId":46588,"journal":{"name":"Health Promotion Perspectives","volume":null,"pages":null},"PeriodicalIF":4.4,"publicationDate":"2023-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558975/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41134498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the role of ChatGPT in patient care (diagnosis and treatment) and medical research: A systematic review 探索ChatGPT在患者护理(诊断和治疗)和医学研究中的作用:系统综述
IF 4.4 Q1 Social Sciences Pub Date : 2023-06-14 DOI: 10.1101/2023.06.13.23291311
R. Garg, V. L. Urs, Akshya Anand Agrawal, Sarvesh Kumar Chaudhary, V. Paliwal, Sujita Kumar Kar
Background ChatGPT(Chat Generative Pre-trained Transformer) is an artificial intelligence (AI) based on a natural language processing tool developed by OpenAI (California, USA). This systematic review examines the potential of Chat GPT in diagnosing and treating patients and its contributions to medical research. Methods In order to locate articles on ChatGPT's use in clinical practise and medical research, this systematic review used PRISMA standards and conducted database searches across several sources. Selected records were analysed using ChatGPT, which also produced a summary for each article. The resultant word document was transformed to a PDF and handled using ChatPDF. The review looked at topics pertaining to scholarly publishing, clinical practise, and medical research. Results We reviewed 118 publications. There are difficulties and moral conundrums associated with using ChatGPT in therapeutic settings and medical research. Patient inquiries, note writing, decision-making, trial enrolment, data management, decision support, research support, and patient education are all things that ChatGPT can help with. However, the solutions it provides are frequently inadequate and inconsistent, presenting issues with its originality, privacy, accuracy, bias, and legality. When utilising ChatGPT for academic writings, there are issues with prejudice and plagiarism, and because it lacks human-like characteristics, its authority as an author is called into question. Conclusions ChatGPT has limitations when used in research and healthcare. Even while it aids in patient treatment, concerns regarding accuracy, authorship, and bias arise. Currently, ChatGPT can serve as a "clinical assistant" and be a huge assistance with research and scholarly writing.
背景ChatGPT(Chat Generative Pre-trained Transformer)是由OpenAI(美国加利福尼亚州)开发的一种基于自然语言处理工具的人工智能。这篇系统综述考察了Chat GPT在诊断和治疗患者方面的潜力及其对医学研究的贡献。方法为了查找关于ChatGPT在临床实践和医学研究中使用的文章,本系统综述使用了PRISMA标准,并在多个来源中进行了数据库搜索。使用ChatGPT对选定的记录进行分析,并为每篇文章生成摘要。生成的word文档被转换为PDF,并使用ChatPDF进行处理。这篇综述着眼于与学术出版、临床实践和医学研究有关的主题。结果我们查阅了118篇文献。在治疗环境和医学研究中使用ChatGPT存在困难和道德难题。ChatGPT可以帮助患者查询、笔记撰写、决策、试验登记、数据管理、决策支持、研究支持和患者教育。然而,它提供的解决方案往往是不充分和不一致的,这给它的独创性、隐私性、准确性、偏见和合法性带来了问题。在使用ChatGPT进行学术写作时,存在偏见和抄袭问题,而且由于它缺乏类似人类的特征,它作为作者的权威性受到质疑。结论ChatGPT在研究和医疗保健中的应用存在局限性。即使它有助于患者治疗,也会引起对准确性、作者身份和偏见的担忧。目前,ChatGPT可以作为“临床助理”,为研究和学术写作提供巨大帮助。
{"title":"Exploring the role of ChatGPT in patient care (diagnosis and treatment) and medical research: A systematic review","authors":"R. Garg, V. L. Urs, Akshya Anand Agrawal, Sarvesh Kumar Chaudhary, V. Paliwal, Sujita Kumar Kar","doi":"10.1101/2023.06.13.23291311","DOIUrl":"https://doi.org/10.1101/2023.06.13.23291311","url":null,"abstract":"Background ChatGPT(Chat Generative Pre-trained Transformer) is an artificial intelligence (AI) based on a natural language processing tool developed by OpenAI (California, USA). This systematic review examines the potential of Chat GPT in diagnosing and treating patients and its contributions to medical research. Methods In order to locate articles on ChatGPT's use in clinical practise and medical research, this systematic review used PRISMA standards and conducted database searches across several sources. Selected records were analysed using ChatGPT, which also produced a summary for each article. The resultant word document was transformed to a PDF and handled using ChatPDF. The review looked at topics pertaining to scholarly publishing, clinical practise, and medical research. Results We reviewed 118 publications. There are difficulties and moral conundrums associated with using ChatGPT in therapeutic settings and medical research. Patient inquiries, note writing, decision-making, trial enrolment, data management, decision support, research support, and patient education are all things that ChatGPT can help with. However, the solutions it provides are frequently inadequate and inconsistent, presenting issues with its originality, privacy, accuracy, bias, and legality. When utilising ChatGPT for academic writings, there are issues with prejudice and plagiarism, and because it lacks human-like characteristics, its authority as an author is called into question. Conclusions ChatGPT has limitations when used in research and healthcare. Even while it aids in patient treatment, concerns regarding accuracy, authorship, and bias arise. Currently, ChatGPT can serve as a \"clinical assistant\" and be a huge assistance with research and scholarly writing.","PeriodicalId":46588,"journal":{"name":"Health Promotion Perspectives","volume":null,"pages":null},"PeriodicalIF":4.4,"publicationDate":"2023-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43770643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
COVID-19 vaccine hesitancy: A Systematic review of cognitive determinants. 新冠肺炎疫苗犹豫:认知决定因素的系统回顾。
IF 4.4 Q1 Social Sciences Pub Date : 2023-04-30 eCollection Date: 2023-01-01 DOI: 10.34172/hpp.2023.03
Sara Pourrazavi, Zahra Fathifar, Manoj Sharma, Hamid Allahverdipour

Background: Although mass vaccination is considered one of the most effective public health strategies during the pandemic, in the COVID-19 era, many people considered vaccines unnecessary and, or doubted the effectiveness of the COVID-19 vaccine. This review aimed to tabulate cognitive causes of COVID-19 vaccination hesitancy, which may help public health policymakers overcome the barriers to mass vaccinations in future pandemics. Methods: For this systematic review, studies pertaining to COVID-19 vaccine hesitancy published up to June 2022 were retrieved from six online databases (Cochrane Library, Google Scholar Medline through PubMed, Scopus, and Web of Science). Inclusion criteria were the studies conducted on people who had a delay in accepting or refusing COVID-19 vaccines, reported the impact of cognitive determinants on vaccine hesitancy, and were written in English in the timeframe of 2020-2022. Results: This systematic review initially reviewed 1171 records. From these 91 articles met the inclusion criteria. The vaccination hesitation rate was 29.72% on average. This systematic review identified several cognitive determinants influencing vaccination hesitancy. Lack of confidence and complacency were the most frequent factors that predicted vaccine hesitancy. Conclusion: The identified prevailing cognitive determinants for COVID-19 vaccine hesitancy indicated that using initiative and effective communication strategies would be a determinant factor in building people's trust in vaccines during the pandemic and mass vaccinations.

背景:尽管大规模疫苗接种被认为是大流行期间最有效的公共卫生策略之一,但在新冠肺炎时代,许多人认为疫苗是不必要的,并怀疑新冠肺炎疫苗的有效性。这项审查旨在将新冠肺炎疫苗接种犹豫的认知原因制成表格,这可能有助于公共卫生政策制定者克服在未来大流行中大规模接种疫苗的障碍。方法:在本系统综述中,从六个在线数据库(Cochrane Library、Google Scholar Medline through PubMed、Scopus和Web of Science)检索截至2022年6月发表的与新冠肺炎疫苗犹豫有关的研究。纳入标准是对延迟接受或拒绝新冠肺炎疫苗的人进行的研究,报告了认知决定因素对疫苗犹豫的影响,并在2020-2022年期间用英语写成。结果:本系统回顾最初回顾了1171份记录。这91篇文章符合入选标准。接种犹豫率平均为29.72%。这项系统综述确定了影响疫苗接种犹豫的几个认知决定因素。缺乏信心和自满情绪是预测疫苗犹豫的最常见因素。结论:已确定的新冠肺炎疫苗犹豫的主要认知决定因素表明,在大流行和大规模疫苗接种期间,使用主动和有效的沟通策略将是建立人们对疫苗信任的决定因素。
{"title":"COVID-19 vaccine hesitancy: A Systematic review of cognitive determinants.","authors":"Sara Pourrazavi,&nbsp;Zahra Fathifar,&nbsp;Manoj Sharma,&nbsp;Hamid Allahverdipour","doi":"10.34172/hpp.2023.03","DOIUrl":"10.34172/hpp.2023.03","url":null,"abstract":"<p><p><b>Background:</b> Although mass vaccination is considered one of the most effective public health strategies during the pandemic, in the COVID-19 era, many people considered vaccines unnecessary and, or doubted the effectiveness of the COVID-19 vaccine. This review aimed to tabulate cognitive causes of COVID-19 vaccination hesitancy, which may help public health policymakers overcome the barriers to mass vaccinations in future pandemics. <b>Methods:</b> For this systematic review, studies pertaining to COVID-19 vaccine hesitancy published up to June 2022 were retrieved from six online databases (Cochrane Library, Google Scholar Medline through PubMed, Scopus, and Web of Science). Inclusion criteria were the studies conducted on people who had a delay in accepting or refusing COVID-19 vaccines, reported the impact of cognitive determinants on vaccine hesitancy, and were written in English in the timeframe of 2020-2022. <b>Results:</b> This systematic review initially reviewed 1171 records. From these 91 articles met the inclusion criteria. The vaccination hesitation rate was 29.72% on average. This systematic review identified several cognitive determinants influencing vaccination hesitancy. Lack of confidence and complacency were the most frequent factors that predicted vaccine hesitancy. <b>Conclusion:</b> The identified prevailing cognitive determinants for COVID-19 vaccine hesitancy indicated that using initiative and effective communication strategies would be a determinant factor in building people's trust in vaccines during the pandemic and mass vaccinations.</p>","PeriodicalId":46588,"journal":{"name":"Health Promotion Perspectives","volume":null,"pages":null},"PeriodicalIF":4.4,"publicationDate":"2023-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257562/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9629823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use and outcomes of antihypertensive medication treatment in the US hypertensive population: A gender comparison. 美国高血压人群抗高血压药物治疗的使用和结果:一项性别比较。
IF 4.4 Q1 Social Sciences Pub Date : 2023-01-01 DOI: 10.34172/hpp.2023.17
Shakir Ullah, Shahbaz Khan, Shahrzad Bazargan-Hejazi, Ernesto Ramirez, Senait Teklehaimanot, Sara Diab, Maria Bangash, Magda Shaheen

Background: Although effective antihypertensive medications have existed for decades, only about half of the hypertensive individuals are considered to have controlled blood pressure. Limited research studies have investigated gender disparity in the utilization and effectiveness of antihypertensive medications treatment. To examine the gender difference in antihypertensive medications' use and the effect of using antihypertensive medication treatment on blood pressure control among the U.S. adult with hypertension.

Methods: Analysis of National Health and Nutrition Examination Survey (NHANES) data from (1999-2012) including individuals≥18 years old with hypertension. Study variables included gender, age, race/ethnicity, obesity, smoking, comorbidities, treatment medication type, and continuity of care. We used multivariate logistic regression in STATA V14. The data is presented as adjusted odds ratios (ORs) and 95% confidence interval (CI).

Results: Of the 15719 participants, 52% were female. 49% of the antihypertensive medication users had their blood pressure under control (95% CI). In the adjusted logistic regression analysis, use of antihypertensive medications was found to be 12% greater in females as compared to males (OR=1.12; CI=1.02-1.22; P<0.05). No association between gender and blood pressure control was found. Blood pressure control was less likely achieved among 50 years or younger individuals, Blacks and Hispanics, obese, and those taking calcium channel blocker (CCB).

Conclusion: Hypertensive females are more likely than males to use antihypertensive medications. The effectiveness of treatment to control blood pressure is equal across males and females. Our findings have implications for practitioners to account gender-specific approaches when discussing adherence to hypertension medication treatment with their patients.

背景:虽然有效的降压药物已经存在了几十年,但只有大约一半的高血压患者被认为血压得到了控制。有限的研究调查了性别差异在抗高血压药物治疗的使用和有效性。目的探讨美国成年高血压患者降压药使用的性别差异及降压药治疗对血压控制的影响。方法:分析1999-2012年全国健康与营养调查(NHANES)数据,包括≥18岁的高血压患者。研究变量包括性别、年龄、种族/民族、肥胖、吸烟、合并症、治疗药物类型和护理的连续性。我们在STATA V14中使用多元逻辑回归。数据以调整后的优势比(ORs)和95%置信区间(CI)表示。结果:15719名参与者中,52%为女性。49%的抗高血压药物使用者血压得到控制(95% CI)。在调整后的logistic回归分析中,女性使用抗高血压药物的比例比男性高12% (OR=1.12;CI = 1.02 - -1.22;结论:女性高血压患者使用降压药的可能性高于男性。控制血压的治疗效果对男性和女性是一样的。我们的研究结果对从业者在与患者讨论高血压药物治疗的依从性时考虑性别特异性方法具有启示意义。
{"title":"Use and outcomes of antihypertensive medication treatment in the US hypertensive population: A gender comparison.","authors":"Shakir Ullah,&nbsp;Shahbaz Khan,&nbsp;Shahrzad Bazargan-Hejazi,&nbsp;Ernesto Ramirez,&nbsp;Senait Teklehaimanot,&nbsp;Sara Diab,&nbsp;Maria Bangash,&nbsp;Magda Shaheen","doi":"10.34172/hpp.2023.17","DOIUrl":"https://doi.org/10.34172/hpp.2023.17","url":null,"abstract":"<p><strong>Background: </strong>Although effective antihypertensive medications have existed for decades, only about half of the hypertensive individuals are considered to have controlled blood pressure. Limited research studies have investigated gender disparity in the utilization and effectiveness of antihypertensive medications treatment. To examine the gender difference in antihypertensive medications' use and the effect of using antihypertensive medication treatment on blood pressure control among the U.S. adult with hypertension.</p><p><strong>Methods: </strong>Analysis of National Health and Nutrition Examination Survey (NHANES) data from (1999-2012) including individuals≥18 years old with hypertension. Study variables included gender, age, race/ethnicity, obesity, smoking, comorbidities, treatment medication type, and continuity of care. We used multivariate logistic regression in STATA V14. The data is presented as adjusted odds ratios (ORs) and 95% confidence interval (CI).</p><p><strong>Results: </strong>Of the 15719 participants, 52% were female. 49% of the antihypertensive medication users had their blood pressure under control (95% CI). In the adjusted logistic regression analysis, use of antihypertensive medications was found to be 12% greater in females as compared to males (OR=1.12; CI=1.02-1.22; <i>P</i><0.05). No association between gender and blood pressure control was found. Blood pressure control was less likely achieved among 50 years or younger individuals, Blacks and Hispanics, obese, and those taking calcium channel blocker (CCB).</p><p><strong>Conclusion: </strong>Hypertensive females are more likely than males to use antihypertensive medications. The effectiveness of treatment to control blood pressure is equal across males and females. Our findings have implications for practitioners to account gender-specific approaches when discussing adherence to hypertension medication treatment with their patients.</p>","PeriodicalId":46588,"journal":{"name":"Health Promotion Perspectives","volume":null,"pages":null},"PeriodicalIF":4.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439450/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10046187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Catastrophic health expenditures in hospitalized patients with delta variant of COVID-19: A cross-sectional study. δ型COVID-19住院患者的灾难性医疗支出:一项横断面研究
IF 4.4 Q1 Social Sciences Pub Date : 2023-01-01 DOI: 10.34172/hpp.2023.09
Zahra Gheinali, Esmaeil Moshiri, Masoumeh Ebrahimi Tavani, Mehdi Haghi, Farid Gharibi

Background: Financial protection of populations against healthcare costs is one of the fundamental responsibilities of governments. This study aimed to investigate the incidence of catastrophic health expenditures (CHE) and it's affecting factors in hospitalized patients with delta variant of COVID-19. Methods: In this cross-sectional study, we included 400 hospitalized COVID-19 patients at Kosar Hospital of Semnan in 2022, using a researcher-made checklist. Based on qualitative nature of the variables, chi-square test was used to investigate the statistical associations between the demographic/background characteristics and the incidence of CHE. Results: On average, COVID-19 imposed 1833.43 USD direct medical costs per one hospitalized patient. The ratio of direct-medical costs to household's non-food expenses was 2.35, and 61% (CI:±4.78%) of the patients were subject to CHE. Besides, residence place, basic insurance type, benefitting from supplementary insurance, suffering from underlying diseases, hospitalization in ICU, falling into a coma, facing pulmonary failure, and performing hemoperfusion had significant associations with CHE (P<0.05). Conclusion: The incidence of CHE in hospitalized COVID-19 patients was undesirable, which may be due to geographical, economical, and occupational inequalities apart from the factors related to the severity of the disease. So, health policymakers should pay attention to the provision of proper financial risk protection policies to make the health insurance system more efficient and appropriate.

背景:从经济上保护民众免受医疗费用的影响是政府的基本责任之一。本研究旨在探讨新型冠状病毒肺炎(COVID-19) δ型变异住院患者灾难性医疗支出(CHE)的发生率及其影响因素。方法:在这项横断面研究中,我们采用研究人员编制的检查表,纳入了2022年在Semnan Kosar医院住院的400例COVID-19患者。基于变量的定性性质,采用卡方检验探讨人口统计学/背景特征与CHE发病率之间的统计学关联。结果:平均每位住院患者因新冠肺炎造成的直接医疗费用为1833.43美元。直接医疗费用与家庭非食品费用之比为2.35,61% (CI:±4.78%)的患者接受了CHE。此外,居住地、基本保险类型、是否参加补充保险、是否患有基础疾病、是否住过ICU、是否昏迷、是否面临肺功能衰竭、是否进行过血液灌流与CHE有显著相关性(p)。结论:住院COVID-19患者CHE的发生率不高,除了与病情严重程度相关的因素外,还可能与地域、经济、职业等方面的不平等有关。因此,卫生政策制定者应注意提供适当的财务风险保护政策,以使医疗保险制度更加有效和适当。
{"title":"Catastrophic health expenditures in hospitalized patients with delta variant of COVID-19: A cross-sectional study.","authors":"Zahra Gheinali,&nbsp;Esmaeil Moshiri,&nbsp;Masoumeh Ebrahimi Tavani,&nbsp;Mehdi Haghi,&nbsp;Farid Gharibi","doi":"10.34172/hpp.2023.09","DOIUrl":"https://doi.org/10.34172/hpp.2023.09","url":null,"abstract":"<p><p><b>Background:</b> Financial protection of populations against healthcare costs is one of the fundamental responsibilities of governments. This study aimed to investigate the incidence of catastrophic health expenditures (CHE) and it's affecting factors in hospitalized patients with delta variant of COVID-19. <b>Methods:</b> In this cross-sectional study, we included 400 hospitalized COVID-19 patients at Kosar Hospital of Semnan in 2022, using a researcher-made checklist. Based on qualitative nature of the variables, chi-square test was used to investigate the statistical associations between the demographic/background characteristics and the incidence of CHE. <b>Results:</b> On average, COVID-19 imposed 1833.43 USD direct medical costs per one hospitalized patient. The ratio of direct-medical costs to household's non-food expenses was 2.35, and 61% (CI:±4.78%) of the patients were subject to CHE. Besides, residence place, basic insurance type, benefitting from supplementary insurance, suffering from underlying diseases, hospitalization in ICU, falling into a coma, facing pulmonary failure, and performing hemoperfusion had significant associations with CHE (<i>P</i><0.05). <b>Conclusion:</b> The incidence of CHE in hospitalized COVID-19 patients was undesirable, which may be due to geographical, economical, and occupational inequalities apart from the factors related to the severity of the disease. So, health policymakers should pay attention to the provision of proper financial risk protection policies to make the health insurance system more efficient and appropriate.</p>","PeriodicalId":46588,"journal":{"name":"Health Promotion Perspectives","volume":null,"pages":null},"PeriodicalIF":4.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257567/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9627319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Understanding the role of intimate partner violence on HIV transmission in Zimbabwe: Secondary data analysis of data from the Zimbabwe demographic survey 2015-2016. 了解亲密伴侣暴力在津巴布韦艾滋病毒传播中的作用:对津巴布韦2015-2016年人口调查数据的二次数据分析。
IF 4.4 Q1 Social Sciences Pub Date : 2023-01-01 DOI: 10.34172/hpp.2023.14
Munyaradzi Mapingure, Tafadzwa Dzinamarira, Zindoga Mukandavire, Innocent Chingombe, Diego F Cuadros, Rouzeh Eghtessadi, Farirai Mutenherwa, Helena Herrera, Roda Madziva, Solomon Mukwenha, Grant Murewanhema, Godfrey Musuka

Background: Gender-based violence (GBV) has been shown to have significant and long-lasting impacts on women's physical and mental health. It is, therefore, important to study its occurrence in a population and its intersect with infectious diseases such as HIV to inform the wider health promotion agenda. This study aimed to determine the association between GBV and HIV status in women and adolescent girls in Zimbabwe.

Methods: A secondary data analysis of data from a cross-sectional Zimbabwe Demographic and Health Survey (ZDHS) was conducted. Statistical analysis was employed to establish the association between GBV and HIV status. Geospatial mapping was conducted using a kernel smoothing method was employed to generate a continuous kernel density surface to illustrate the local spatial variations of female HIV and GBV prevalence.

Results: Women and adolescent girls suffering emotional GBV, such as those subjected to humiliation by their husbands or partners, were 1.45 (1.14-1.84) [OR (95% CIs)] times more likely to be HIV positive than those who were never humiliated. The same was true for women and adolescent girls whose husbands or partners threatened to harm them or someone they love, 1.33 (1.04-1.68). There is a relationship between women's HIV status and intimate partner aggression, such as when their partners pushed, shook, or threw something at them or physically abused them. This was also the case for those who reported that partners kicked, dragged, or beat them, tried to choke or burn them on purpose, or threatened or attacked them with a knife, gun, or other weapons. Women who experienced forced sexual violence with threats were more likely 1.61 (1.08-2.41), to be HIV positive than those women who did not experience the same.

Conclusion: GBV is widely spread in Zimbabwe. There is a need for the government to implement creative strategies to reach out to survivors, especially those that are forced to have unprotected sex and are at increased risk of HIV acquisition. This manuscript raises issues that can be addressed by robust health promotion strategies to reduce the impact of the syndemic of GBV and HIV acquisition in Zimbabwe.

背景:基于性别的暴力(GBV)已被证明对妇女的身心健康产生重大和持久的影响。因此,重要的是研究其在人群中的发病率及其与艾滋病毒等传染病的关系,以便为更广泛的健康促进议程提供信息。本研究旨在确定津巴布韦妇女和少女中性别暴力与艾滋病毒状况之间的关系。方法:对横断面津巴布韦人口与健康调查(ZDHS)的数据进行二次数据分析。统计分析建立GBV与HIV状态之间的关系。采用核平滑法进行地理空间映射,生成连续核密度曲面,以反映女性HIV和GBV感染率的局部空间变化。结果:遭受情感GBV的妇女和少女,如遭受丈夫或伴侣羞辱的妇女和少女,其艾滋病毒阳性的可能性是从未遭受羞辱的妇女和少女的1.45 (1.14-1.84)[or (95% ci)]倍。对于那些丈夫或伴侣威胁要伤害她们或她们所爱的人的女性和青春期女孩来说,这一比例也是1.33(1.04-1.68)。妇女的艾滋病毒状况与亲密伴侣的侵犯之间存在关系,例如当她们的伴侣推、摇或向她们扔东西或对她们进行身体虐待时。这也适用于那些报告伴侣踢、拖或打他们,试图故意掐死或烧伤他们,或用刀、枪或其他武器威胁或攻击他们的人。遭受过带有威胁的强迫性暴力的妇女比没有经历过的妇女更有可能感染艾滋病毒。结论:性别暴力在津巴布韦广泛传播。政府有必要实施创造性的策略来帮助幸存者,特别是那些被迫进行无保护的性行为和感染艾滋病毒风险增加的人。这份手稿提出了可以通过强有力的健康促进战略来解决的问题,以减少性别暴力和艾滋病毒感染在津巴布韦的影响。
{"title":"Understanding the role of intimate partner violence on HIV transmission in Zimbabwe: Secondary data analysis of data from the Zimbabwe demographic survey 2015-2016.","authors":"Munyaradzi Mapingure,&nbsp;Tafadzwa Dzinamarira,&nbsp;Zindoga Mukandavire,&nbsp;Innocent Chingombe,&nbsp;Diego F Cuadros,&nbsp;Rouzeh Eghtessadi,&nbsp;Farirai Mutenherwa,&nbsp;Helena Herrera,&nbsp;Roda Madziva,&nbsp;Solomon Mukwenha,&nbsp;Grant Murewanhema,&nbsp;Godfrey Musuka","doi":"10.34172/hpp.2023.14","DOIUrl":"https://doi.org/10.34172/hpp.2023.14","url":null,"abstract":"<p><strong>Background: </strong>Gender-based violence (GBV) has been shown to have significant and long-lasting impacts on women's physical and mental health. It is, therefore, important to study its occurrence in a population and its intersect with infectious diseases such as HIV to inform the wider health promotion agenda. This study aimed to determine the association between GBV and HIV status in women and adolescent girls in Zimbabwe.</p><p><strong>Methods: </strong>A secondary data analysis of data from a cross-sectional Zimbabwe Demographic and Health Survey (ZDHS) was conducted. Statistical analysis was employed to establish the association between GBV and HIV status. Geospatial mapping was conducted using a kernel smoothing method was employed to generate a continuous kernel density surface to illustrate the local spatial variations of female HIV and GBV prevalence.</p><p><strong>Results: </strong>Women and adolescent girls suffering emotional GBV, such as those subjected to humiliation by their husbands or partners, were 1.45 (1.14-1.84) [OR (95% CIs)] times more likely to be HIV positive than those who were never humiliated. The same was true for women and adolescent girls whose husbands or partners threatened to harm them or someone they love, 1.33 (1.04-1.68). There is a relationship between women's HIV status and intimate partner aggression, such as when their partners pushed, shook, or threw something at them or physically abused them. This was also the case for those who reported that partners kicked, dragged, or beat them, tried to choke or burn them on purpose, or threatened or attacked them with a knife, gun, or other weapons. Women who experienced forced sexual violence with threats were more likely 1.61 (1.08-2.41), to be HIV positive than those women who did not experience the same.</p><p><strong>Conclusion: </strong>GBV is widely spread in Zimbabwe. There is a need for the government to implement creative strategies to reach out to survivors, especially those that are forced to have unprotected sex and are at increased risk of HIV acquisition. This manuscript raises issues that can be addressed by robust health promotion strategies to reduce the impact of the syndemic of GBV and HIV acquisition in Zimbabwe.</p>","PeriodicalId":46588,"journal":{"name":"Health Promotion Perspectives","volume":null,"pages":null},"PeriodicalIF":4.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439455/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10039802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
FANTASTIC lifestyle questionnaire from 1983 until 2022: A review. 从1983年到2022年的奇妙生活方式问卷:回顾。
IF 4.4 Q1 Social Sciences Pub Date : 2023-01-01 DOI: 10.34172/hpp.2023.11
Patrícia Batista, João Neves-Amado, Anabela Pereira, João Amado

Background: Studying lifestyles has always been important; quantifying them has become more complex. However, a questionnaire produced in 1983 has shown that its simple form of evaluation can be an added value in understanding lifestyles. Our aim is a systematic review of the scientific literature about the use of the FANTASTIC Lifestyle questionnaire (FLQ).

Methods: The reflective systematic literature review on PubMed, Medline, Science Direct, and SCIELO databases with the descriptors "FANTASTIC Lifestyle questionnaire" OR "FANTASTICO questionnaire" OR "FANTASTIC questionnaire" OR "FANTASTIC survey" OR "FANTASTIC checklist". PRISMA criteria reporting of systematic reviews and meta-analyses were applied. The inclusion criteria were the use of FLQ instrument to measure lifestyles, presenting quantitative or qualitative results, and psychometric studies. It excluded other lifestyle instruments, incomplete articles, and non-English, Brazilian, Spanish, and Portuguese language articles.

Results: Findings reveal 41 scientific articles included in the study. It analyzed the results and most studies use the instrument to assess all dimensions. However, some studies reported assessing specific dimensions such as nutrition, sleep, stress, tobacco, alcohol, and drugs. The questionnaire has been applied to a wide range of ages and literacy levels.

Conclusion: This literature review allowed us to conclude that this questionnaire is still in use today and is applied in several contexts and populations. It is also possible to verify the relevance of its use and to design intervention strategies and programs for a healthy society. It is essential to draw attention to this issue and promote health literacy (HL) on this topic.

背景:研究生活方式一直很重要;量化它们变得更加复杂。然而,1983年制作的一份问卷显示,其简单的评估形式可以成为了解生活方式的附加价值。我们的目的是系统地回顾关于使用奇妙生活方式问卷(FLQ)的科学文献。方法:在PubMed、Medline、Science Direct和SCIELO数据库中采用“奇妙生活方式问卷”或“FANTASTICO问卷”或“奇妙问卷”或“奇妙调查”或“奇妙清单”等描述语进行反思性系统文献综述。采用PRISMA标准报告系统评价和荟萃分析。纳入标准为使用FLQ仪器测量生活方式,呈现定量或定性结果,以及心理测量学研究。它排除了其他生活方式工具、不完整的文章和非英语、巴西语、西班牙语和葡萄牙语的文章。结果:研究结果揭示了研究中包含的41篇科学论文。它分析了结果,大多数研究使用该工具来评估所有维度。然而,一些研究报告评估了具体的方面,如营养、睡眠、压力、烟草、酒精和药物。问卷适用于不同年龄和文化水平的人群。结论:这篇文献综述让我们得出结论,这个问卷仍然在今天使用,并在几个背景和人群中应用。还可以验证其使用的相关性,并为健康社会设计干预策略和方案。必须引起人们对这一问题的注意,并促进有关这一主题的卫生知识普及。
{"title":"FANTASTIC lifestyle questionnaire from 1983 until 2022: A review.","authors":"Patrícia Batista,&nbsp;João Neves-Amado,&nbsp;Anabela Pereira,&nbsp;João Amado","doi":"10.34172/hpp.2023.11","DOIUrl":"https://doi.org/10.34172/hpp.2023.11","url":null,"abstract":"<p><strong>Background: </strong>Studying lifestyles has always been important; quantifying them has become more complex. However, a questionnaire produced in 1983 has shown that its simple form of evaluation can be an added value in understanding lifestyles. Our aim is a systematic review of the scientific literature about the use of the FANTASTIC Lifestyle questionnaire (FLQ).</p><p><strong>Methods: </strong>The reflective systematic literature review on PubMed, Medline, Science Direct, and SCIELO databases with the descriptors \"FANTASTIC Lifestyle questionnaire\" OR \"FANTASTICO questionnaire\" OR \"FANTASTIC questionnaire\" OR \"FANTASTIC survey\" OR \"FANTASTIC checklist\". PRISMA criteria reporting of systematic reviews and meta-analyses were applied. The inclusion criteria were the use of FLQ instrument to measure lifestyles, presenting quantitative or qualitative results, and psychometric studies. It excluded other lifestyle instruments, incomplete articles, and non-English, Brazilian, Spanish, and Portuguese language articles.</p><p><strong>Results: </strong>Findings reveal 41 scientific articles included in the study. It analyzed the results and most studies use the instrument to assess all dimensions. However, some studies reported assessing specific dimensions such as nutrition, sleep, stress, tobacco, alcohol, and drugs. The questionnaire has been applied to a wide range of ages and literacy levels.</p><p><strong>Conclusion: </strong>This literature review allowed us to conclude that this questionnaire is still in use today and is applied in several contexts and populations. It is also possible to verify the relevance of its use and to design intervention strategies and programs for a healthy society. It is essential to draw attention to this issue and promote health literacy (HL) on this topic.</p>","PeriodicalId":46588,"journal":{"name":"Health Promotion Perspectives","volume":null,"pages":null},"PeriodicalIF":4.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439457/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10046190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Monkeypox: A review of a zoonotic disease of global public health concern. 猴痘:一种引起全球公共卫生关注的人畜共患疾病综述。
IF 4.4 Q1 Social Sciences Pub Date : 2023-01-01 DOI: 10.34172/hpp.2023.01
Yusuf Amuda Tajudeen, Habeebullah Jayeola Oladipo, Abdulbasit Opeyemi Muili, Joy Ginika Ikebuaso

Background: The rising circulation of the monkeypox virus while the COVID-19 is still ongoing in non-endemic countries is a significant global health threat. In this article, we have discussed the epidemiology, aetiology, and pathogenesis of the monkeypox virus to provide our current knowledge of the disease. Also, we discussed the ongoing efforts of the international health organizations to curtail the present epidemic and we finally provide recommendations for early detection and response. Methods: We did a rapid literature search on PubMed, EMBASE, World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), and other trusted databases for recent articles (1958-2022) published in English-focusing on the outbreaks of monkeypox disease, epidemiology, pathogenesis, aetiology, prevention, and control in endemic and non-endemic countries. Keywords such as "Monkeypox", "Monkeypox virus", "Poxviridae", "Orthopoxvirus", "Smallpox", and "Smallpox Vaccine" were considered in our search based on MESH medical subject headings. Results: Our review highlights four important findings. First, a cumulative of 1285 monkeypox cases have been documented and reported by the WHO in non-endemic countries as of June 8, 2022. Second, international travel contributes to the increase in cases in non-endemic countries. Third, the origin of the outbreak, the pattern of transmission, and the risk of infections is not fully understood. Fourth, there is an ongoing effort by the WHO, CDC, and other international health organization to control the spread of the monkeypox disease. Conclusion: Our findings underline the need to reassess research priorities on the origin, transmission pattern, and risk factors for infection of monkeypox. Also, we provide recommendations under the One Health spectrum to prevent further spread of the disease.

背景:当COVID-19在非流行国家仍在流行时,猴痘病毒的传播却在上升,这是一个重大的全球健康威胁。在本文中,我们讨论了猴痘病毒的流行病学、病原学和发病机制,以提供我们目前对该病的了解。此外,我们讨论了国际卫生组织为遏制目前的流行病正在进行的努力,我们最后提出了早期发现和反应的建议。方法:我们在PubMed、EMBASE、世界卫生组织(WHO)、美国疾病控制与预防中心(CDC)和其他可信的数据库中快速检索了最近发表的英文文章(1958-2022),重点是猴痘病的爆发、流行病学、发病机制、病因学、预防和控制在流行和非流行国家。基于MESH医学主题标题的搜索中考虑了诸如“猴痘”、“猴痘病毒”、“痘病毒科”、“正痘病毒”、“天花”和“天花疫苗”等关键词。结果:我们的综述突出了四个重要发现。首先,截至2022年6月8日,世卫组织在非流行国家累计记录和报告了1285例猴痘病例。第二,国际旅行导致非流行国家的病例增加。第三,疫情的起源、传播模式和感染风险尚未完全了解。第四,世界卫生组织、美国疾病控制与预防中心和其他国际卫生组织正在努力控制猴痘疾病的传播。结论:我们的研究结果强调需要重新评估猴痘感染的起源、传播方式和危险因素的研究重点。此外,我们在同一个健康范围内提供建议,以防止疾病的进一步传播。
{"title":"Monkeypox: A review of a zoonotic disease of global public health concern.","authors":"Yusuf Amuda Tajudeen,&nbsp;Habeebullah Jayeola Oladipo,&nbsp;Abdulbasit Opeyemi Muili,&nbsp;Joy Ginika Ikebuaso","doi":"10.34172/hpp.2023.01","DOIUrl":"https://doi.org/10.34172/hpp.2023.01","url":null,"abstract":"<p><p><b>Background:</b> The rising circulation of the monkeypox virus while the COVID-19 is still ongoing in non-endemic countries is a significant global health threat. In this article, we have discussed the epidemiology, aetiology, and pathogenesis of the monkeypox virus to provide our current knowledge of the disease. Also, we discussed the ongoing efforts of the international health organizations to curtail the present epidemic and we finally provide recommendations for early detection and response. <b>Methods:</b> We did a rapid literature search on PubMed, EMBASE, World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), and other trusted databases for recent articles (1958-2022) published in English-focusing on the outbreaks of monkeypox disease, epidemiology, pathogenesis, aetiology, prevention, and control in endemic and non-endemic countries. Keywords such as \"Monkeypox\", \"Monkeypox virus\", \"Poxviridae\", \"Orthopoxvirus\", \"Smallpox\", and \"Smallpox Vaccine\" were considered in our search based on MESH medical subject headings. <b>Results:</b> Our review highlights four important findings. First, a cumulative of 1285 monkeypox cases have been documented and reported by the WHO in non-endemic countries as of June 8, 2022. Second, international travel contributes to the increase in cases in non-endemic countries. Third, the origin of the outbreak, the pattern of transmission, and the risk of infections is not fully understood. Fourth, there is an ongoing effort by the WHO, CDC, and other international health organization to control the spread of the monkeypox disease. <b>Conclusion:</b> Our findings underline the need to reassess research priorities on the origin, transmission pattern, and risk factors for infection of monkeypox. Also, we provide recommendations under the One Health spectrum to prevent further spread of the disease.</p>","PeriodicalId":46588,"journal":{"name":"Health Promotion Perspectives","volume":null,"pages":null},"PeriodicalIF":4.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257565/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9627314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Health Promotion Perspectives
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1